ELEVATED SERUM BRAIN INJURY MARKERS CORRELATE WITH DISEASE FEATURES AND INTERFERONS IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Bibliographic record
Abstract
O044 / #255 Topic:AS05 - CNS Lupus ABSTRACT CONCURRENT SESSION 07: COGNITION IMPAIRMENT IN SLE – RECENT ADVANCEMENT AND EMERGING RESEARCH 23-05-2025 1:40 PM - 2:40 PM Background/Purpose Childhood-onset systemic lupus erythematosus (cSLE) involves interferon (IFN)-mediated inflammation emerging during the critical period of adolescent brain development. Neuropsychiatric lupus (NPSLE) manifests as syndromes like cognitive dysfunction, seizures, and psychiatric disorders, which negatively impact education, psychosocial functioning, and quality of life. While previous work indicates a type I IFN-α signature in cSLE, the levels of type II IFN-γ as well as the roles of both IFNs in the pathogenesis of brain inflammation have not been well established in literature. Moreover, clinicians face challenges diagnosing/treating brain inflammation in cSLE, due to suboptimal diagnostic tools. Neuronal/glial structural proteins may be useful biomarkers of brain injury in cSLE. We aimed to i) compare serum levels of brain injury markers and IFNs between children with cSLE and controls; and ii) investigate the relationship of brain injury markers to cSLE disease features and serum IFN levels. Methods We utilized prospectively-collected cross-sectional data from cSLE participants (ages 12-17 years) recruited from the Lupus Clinic at a Canadian tertiary children’s hospital from January 2020–December 2023, and age-, sex-matched healthy controls. Serum brain injury markers (serum neurofilament light (sNFL), glial fibrillary acidic protein (GFAP), Tau) were quantified using Simoa Human Neurology 4–Plex B assay; IFN-α and IFN-γ were also quantified with their respective Simoa assays (Quanterix, Billerca, MA, USA). Disease features included disease activity (SLEDAI-2K), damage (SLICC damage index, SDI > 0), glucocorticoid (GC) dose at study visit, and cumulative GC exposure (prednisone equivalent). Wilcoxon rank sum test was used to compare markers/IFNs between cSLE and controls, and Spearman correlation tested associations. Results 56 cSLE participants (mean age = 15.1 ± 1.8 years, 86% female) and 43 controls (mean age = 15.1 ± 1.7 years, 81% female) were included. For cSLE, median disease duration was 22.6 months (IQR 12.5-43.9), median SLEDAI-2K was 2.5 (IQR 2.0-5.3), 9% had disease damage, 41% were using glucocorticoids at study visit, and median cumulative GC exposure was 1.9 grams (IQR 0.6-6.9). One patient had a NPSLE diagnosis. GFAP (114.0 vs 74.3 pg/mL) and Tau (3.57 vs 2.58 pg/mL) serum levels were significantly higher in cSLE compared to controls (Figure 1), as were serum IFN-α (0.278 vs 0.018 pg/mL) and IFN-γ (0.100 vs 0.068 pg/mL) levels (all p < 0.05). All brain injury markers had significant positive correlations with SLEDAI-2K and GC dose; sNFL and Tau associated with disease damage (Table 1). Higher levels of sNFL and GFAP correlated with IFN-α, while GFAP also associated with IFN-γ (Table 1). No correlations were found between Tau and IFNs. Table 1: Relationship between Brain Injury Markers, Disease Characteristics, and Interferons in cSLE (n=56) Figure 1: Boxplots showing group differences in serum brain injury marker levels between cSLE and controls. GFAP and Tau were significantly elevated in cSLE group (Wilcoxon rank sum test, p < 0.05), with outliers also observed across all brain injuiy markers for cSLE. Conclusions Serum brain injury markers and type I and II IFNs were elevated in cSLE, with brain injury markers correlating with disease features, IFN-α, and IFN-γ. This suggests a link between IFN-mediated inflammation and neuronal/glial injury, and potential utility of sNFL, GFAP and Tau as diagnostic and monitoring biomarkers in cSLE. Also, these results indicate IFNs are potential therapeutic targets in cSLE. Future studies will explore relationships between brain injury markers and IFNs in larger cSLE cohorts over time.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.001 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".